[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address Please contact the publisher to request reinstatement.
[Skip to Content Landing]
January 1999

Acute Generalized Exanthematous Pustulosis Induced by Metronidazole: The Role of Patch Testing

Author Affiliations

Not Available

Arch Dermatol. 1999;135(1):93-94. doi:10-1001/pubs.Arch Dermatol.-ISSN-0003-987x-135-1-dlt0199

The challenge of cutaneous adverse drug reactions for the consultant dermatologist is in determining a specific etiologic agent, especially in the setting of polypharmacy. The risk of reexposure to individual medications usually outweighs the benefits, especially in the case of severe drug eruptions. Recently, patch testing has been advocated as a potentially useful test in some severe cutaneous adverse drug reactions, especially acute generalized exanthematous pustulosis (AGEP).1

First Page Preview View Large
First page PDF preview
First page PDF preview